Entry Detail



General Information

Database ID:exR0759293
RNA Name:HLA-B
RNA Type:mRNA
Chromosome:chr6
Starnd:-
Coordinate:
Start Site(bp):31269491End Site(bp):31357188
External Links:ENSG00000234745



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ACTA2
chr10
88935074
88991339
-
ACTG1
chr17
81509971
81523847
-
ADPRHL2
chr1
36088892
36093932
+
AK4
chr1
65147549
65232145
+
AC092647.5
chr7
55887277
55955239
+
ADM
chr11
10305073
10307397
+
AHCY
chr20
34280268
34311802
-
ACTB
chr7
5527148
5563784
-
ABCC10
chr6
43427366
43450427
+
ACOT7
chr1
6264269
6394391
-
ADAR
chr1
154582057
154628013
-
AGTRAP
chr1
11736084
11754802
+
ADI1
chr2
3497366
3519531
-
AK2
chr1
33007940
33080996
-
ABLIM1
chr10
114431113
114768061
-
AC069503.2
chr12
121888809
121921470
+
AL109827.1
chr20
35632340
35674544
-
AGAP3
chr7
151085831
151144436
+
AC011462.1
chr19
41350853
41425001
+
AC135050.2
chr16
31083439
31094956
-
AC046185.1
chr17
63702845
63752097
-
ADRM1
chr20
62302093
62308862
+
AC010422.3
chr19
12643831
12648397
-
AC005258.1
chr19
2269525
2341172
+
ADGRG2
chrX
18989307
19122637
-
ACTR3
chr2
113890063
113962596
+
ADCY1
chr7
45574140
45723116
+
ACTA1
chr1
229431245
229434098
-
ACADSB
chr10
123008979
123058290
+
AICDA
chr12
8602170
8612867
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-155-5p
chr21
25573983
25574006
+
hsa-miR-6891-5p
chr6
31355297
31355315
-
hsa-miR-6516-5p
chr17
77089428
77089449
+
hsa-miR-6516-3p
chr17
77089469
77089490
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002470.2
chr22
20979462
20998121
+
AC006942.1
chr19
49808933
49809738
+
AC019205.1
chr6
73263212
73301789
+
AC023509.1
chr12
53441741
53467528
+
AC067852.2
chr17
42552436
42554748
-
AC091564.7
chr11
6610883
6616594
-
AC093157.1
chr1
101025844
101090513
+
AC134043.2
chr5
159209921
159248796
+
AC139530.1
chr17
81701324
81703300
-
AC147651.4
chr7
603185
608482
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.